Oklahoma university Health Science Center

Oklahoma City, Oklahoma 73104

2 studies enrolling now · 17 studies all time

What they study most

Brain Cancer, Brain Tumor, Breast Cancer, Cardiovascular Disease, Colorectal Cancer, Crohn Disease, Cushing's Syndrome, GBM, Glioblastoma, Glioblastoma Multiforme, Glioma, Gliosarcoma

Studies at this site

• Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy — Recruiting now
• Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes — Recruiting now
• A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Pediatric Urology Recovery After Surgery Endeavor (PURSUE) — Running, not enrolling
• Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease — Enrolling by invitation
• INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme — Completed
• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
• Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure — Completed
• Post Market Study Using the Xoft Axxent System — Completed
• Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer — Completed
• Innovative Multigenerational Household Intervention to Reduce Stroke and CVD — Completed
• Efficacy of Statins In Prevention of CIN — Stopped early
• Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis — Completed
• A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome — Completed
• Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis — Completed
• A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer — Stopped early
• Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Carriage Rates in Resident Physicians — Stopped early